Id |
Subject |
Object |
Predicate |
Lexical cue |
T33 |
0-29 |
Sentence |
denotes |
ACE System and ACE2 Discovery |
T34 |
30-253 |
Sentence |
denotes |
Human Angiotensin-converting enzyme (ACE) belongs to the M2 gluzincin family of metalloproteinases and (Ehlers and Riordan, 1989; Masuyer et al., 2014) exists in two forms, namely somatic ACE (sACE) and germinal ACE (tACE). |
T35 |
254-476 |
Sentence |
denotes |
Both are derived from the same gene, controlled by alternative promotors. sACE is an integral membrane protein, which can be also cleaved by ACE secretases to produce a circulating form of the enzyme (Natesh et al., 2003). |
T36 |
477-713 |
Sentence |
denotes |
sACE, hereafter referred to simply as ACE, has been extensively studied, because of its crucial role in the homeostasis of renin-angiotensin-aldosterone (RAAS) system and in cardiovascular diseases (Takimoto-Ohnishi and Murakami, 2019). |
T37 |
714-947 |
Sentence |
denotes |
The two extracellular domains N and C domains of ACE (Wei et al., 1991; Jaspard et al., 1993; Natesh et al., 2003; Riordan, 2003) can both hydrolase two crucial peptides, namely angiotensin I and bradykinin, with the same efficiency. |
T38 |
948-1168 |
Sentence |
denotes |
Indeed, ACE carries out the cleavage of two amino acids (dipeptidase action) from the C-terminal part of angiotensin I to generate angiotensin II, which exerts a potent vasopressor, proliferative, and profibrotic effect. |
T39 |
1169-1280 |
Sentence |
denotes |
Moreover, ACE mediates the cleavage and inactivation of bradykinin, which is a vasodilator hypotensive peptide. |
T40 |
1281-1408 |
Sentence |
denotes |
The pivotal role of ACE in the RAAS system allows a refined blood pressure control and salt homeostasis (Sayer and Bhat, 2014). |
T41 |
1409-1597 |
Sentence |
denotes |
Following the ACE discovery in mid-1950s, despite intense research in the field, no human homologs of the enzyme have been found for more than 50 years (Isaac et al., 1998; Riordan, 2003). |
T42 |
1598-1749 |
Sentence |
denotes |
It was only in 2000 that two independent research groups identified, almost simultaneously, a new human ACE-like enzyme, with two different approaches. |
T43 |
1750-1929 |
Sentence |
denotes |
Tipnis et al. (2000) searched for new metalloproteases in an expressed sequence tag (EST) database, finding an ACE homolog (ACEH) with a single domain, similar to that of insects. |
T44 |
1930-1993 |
Sentence |
denotes |
Subsequently they cloned it from a human lymphoma cDNA library. |
T45 |
1994-2182 |
Sentence |
denotes |
Interestingly ACEH showed high homology (40% identity and 60% similarity) with ACE, particularly around the HEXXH sequence and highly conserved glutamate residue, involved in zinc binding. |
T46 |
2183-2275 |
Sentence |
denotes |
Moreover, they demonstrated the presence of seven glycosylation sites (Tipnis et al., 2000). |
T47 |
2276-2596 |
Sentence |
denotes |
In the same year, Donoghue et al. (2000b) were searching for new genes involved in heart failure and identified a human cDNA ACE homolog, named ACE2, among 19,000 5’end sequences by RACE (rapid amplification of cDNA ends) in the heart ventricle cDNA library, obtained from a woman with idiopathic dilated cardiomyopathy. |
T48 |
2597-2699 |
Sentence |
denotes |
ACE2 showed a transmembrane domain, a zinc catalytic domain 42% identical to ACE and a signal peptide. |
T49 |
2700-2757 |
Sentence |
denotes |
Like ACE, ACE2 seemed to be an ectoenzyme type I protein. |
T50 |
2758-2926 |
Sentence |
denotes |
The authors identified ACE2 transcripts quite exclusively in the heart and in the kidney, suggesting a role for ACE2 in the local RAAS control (Donoghue et al., 2000b). |
T51 |
2927-3066 |
Sentence |
denotes |
In the following years, ACE2 was intensively studied, its structure and function were enlightened, and tentative inhibitors were developed. |